Discover
RCUS
Arcus Biosciences, Inc.
28.92
100 x undefined
200 x undefined
bid
ask
-
1.91
6.20%
150 @ 07:10 AM
30.05 +1.13 (3.91%)
| Ytd | 21.36% | |
| 1y | 236.67% |
28.77
day range
31.32
8.03
52 week range
31.73
| Open | 30.98 | Prev Close | 30.83 | Low | 28.77 | High | 31.32 | Mkt Cap | 3.64B |
| Vol | 1.61M | Avg Vol | 1.31M | EPS | -3.17 | P/E | N/A | Forward P/E | -9.93 |
| Beta | 0.84 | Short Ratio | 12.25 | Inst. Own | 72.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 25.28 | 200-d Avg | 21.67 | 1yr Est | 35.75 |
| Income Statement | |||
| Total Revenue | 17.00M | ||
| Revenues (USD) | 17.00M | ||
| Gross Profit | 17.00M | ||
| Operating Expenses | 151.00M | ||
| Research and Development Expense | 122.00M | ||
| Selling, General and Administrative Expense | 29.00M | ||
| Operating Income | -134.00M | ||
| Interest Expense | 3.00M | ||
| Net Income | -128.00M | ||
| Net Income Common Stock | -128.00M | ||
| Net Income Common Stock (USD) | -128.00M | ||
| Consolidated Income | -128.00M | ||
| Earnings per Basic Share | -1.02 | ||
| Earnings per Basic Share (USD) | -1.02 | ||
| Earnings per Diluted Share | -1.02 | ||
| Earning Before Interest & Taxes (EBIT) | -125.00M | ||
| Earning Before Interest & Taxes (USD) | -125.00M | ||
| Weighted Average Shares | 125.40M | ||
| Weighted Average Shares Diluted | 125.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 201.00M | ||
| Cash and Equivalents (USD) | 201.00M | ||
| Investments | 675.00M | ||
| Investments Current | 621.00M | ||
| Investments Non-Current | 54.00M | ||
| Trade and Non-Trade Receivables | 3.00M | ||
| Current Assets | 844.00M | ||
| Property, Plant & Equipment Net | 38.00M | ||
| Total Assets | 997.00M | ||
| Total Debt | 100.00M | ||
| Current Liabilities | 209.00M | ||
| Debt Non-Current | 100.00M | ||
| Total Liabilities | 473.00M | ||
| Accumulated Retained Earnings (Deficit) | -1.61B | ||
| Accumulated Other Comprehensive Income | -1000.00K | ||
| Shareholders Equity | 524.00M | ||
| Shareholders Equity (USD) | 524.00M | ||
| Assets Non-Current | 153.00M | ||
| Total Debt (USD) | 100.00M | ||
| Deferred Revenue | 79.00M | ||
| Liabilities Non-Current | 264.00M | ||
| Trade and Non-Trade Payables | 39.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.00M | ||
| Net Cash Flow from Financing | 3.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -21.00M | ||
| Issuance (Purchase) of Equity Shares | 3.00M | ||
| Net Cash Flow from Investing | 114.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 114.00M | ||
| Net Cash Flow from Operations | -138.00M | ||
| Share Based Compensation | 19.00M | ||